Pfizer Inc., manufacturer of Lipitor, Effexor, Zoloft and numerous other medications, has agreed to pay $325 million to resolve a decade-old lawsuit over Neurontin, a drug developed to treat epilepsy. Pfizer was accused of selling the drug without approval by the U.S. Food and Drug Administration and without medical support for its claimed benefits, in an attempt to maximize profits.
This is not ...
continue reading...An estimated 29 million Americans take Lipitor, a prescription medication that works to lower cholesterol, as well as the risk of stroke, chest pains, heart attack, and other blood vessel and heart problems. While meant to help patients stay healthy, many people blame the drug for the development of some dangerous health conditions. In fact, many Americans who took Lipitor have filed lawsuits alleging that Lipitor caused Type 2 diabetes in women.
If you are a woman and have developed ...
continue reading...
In recent research from the U.S. National Health and Nutrition Examination Survey, black Americans were found to have the highest rate of diabetic macular edema, a complication of diabetes that is one of the leading causes of blindness. A story in Medline Plus details the research and conclusions that were reached.
Diabetic macular edema causes blindness primarily as a result of retinal swelling. Parts of the retina can accumulate a buildup of fluid and protein which ...
continue reading...
Type 2 diabetes is most commonly associated with obesity and lack of exercise, yet new research suggests that many other factors are in play. A story from Medline Plus details new studies that seek to further understand these contributing factors to the development of Type 2 diabetes. For example, recent research has shown a strong correlation between the development of diabetes and genetic mutations, family history, and a hormone called amylin. Lipitor is also linked ...
Lopez McHugh LLP is pleased to announce that principal partner Ramon R. Lopez has been appointed to the Plaintiffs’ Executive Committee (PEC) in the multidistrict litigation (MDL) regarding Lipitor, titled In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation (MDL – 2502). 270 claims were filed against Pfizer, maker of Lipitor, and have been consolidated into this MDL, which was centralized in the United States District ...
A new study has emerged that links statin medication to the risk of developing cataracts, according to US News and World Report.
Researchers with the VA North Texas Health System published study results in the online edition of JAMA Ophthalmology, in which they analyzed data from over 14,000 statin users. They found that statin users had a 27% greater risk of developing cataracts. Even after analyzing the data several different ways, the same association emerged: statin use was ...
continue reading...
